OBJECTIVE: To investigate the effects of soy isoflavones on mood and cognitive function in postmenopausal women. DESIGN: Randomized, double-blind, cross-over, placebo-controlled trial. SETTING: University Hospital, Milan, Italy; A.G.UN.CO. Obstetrics and Gynaecology Centre, Rome, Italy. PATIENT(S): Seventy-eight postmenopausal women. INTERVENTION(S): We administered 60 mg/day isoflavones or placebo for 6 months. After a washout period of 1 month, the patients who had been treated with phytoestrogens receivedplacebo, and those who previously received placebo were administered phytoestrogens (for 6 months). MAIN OUTCOME MEASURE(S): Cognitive performance and mood were assessed by a battery of tests at the end of each treatment period. At the end of the study, the patients were also asked whether they preferred the first or second treatment. RESULT(S): The 17 scores on cognitive performance test and the 6 for mood assessments 6 showed an advantage for the treatment with phytoestrogens. Similarly, of the 8 visual analogue scales used to indicate mood, 7 improved significantly after the treatment with phytoestrogens. Moreover, 49 patients preferred phytoestrogens, 9 placebo, and 18 had no preference. The preference was not related to the order of treatment. CONCLUSION(S): These results suggest that isoflavones may have positive effects on postmenopausal women improving cognitive performance and mood.
RCT Entities:
OBJECTIVE: To investigate the effects of soy isoflavones on mood and cognitive function in postmenopausal women. DESIGN: Randomized, double-blind, cross-over, placebo-controlled trial. SETTING: University Hospital, Milan, Italy; A.G.UN.CO. Obstetrics and Gynaecology Centre, Rome, Italy. PATIENT(S): Seventy-eight postmenopausal women. INTERVENTION(S): We administered 60 mg/day isoflavones or placebo for 6 months. After a washout period of 1 month, the patients who had been treated with phytoestrogens received placebo, and those who previously received placebo were administered phytoestrogens (for 6 months). MAIN OUTCOME MEASURE(S): Cognitive performance and mood were assessed by a battery of tests at the end of each treatment period. At the end of the study, the patients were also asked whether they preferred the first or second treatment. RESULT(S): The 17 scores on cognitive performance test and the 6 for mood assessments 6 showed an advantage for the treatment with phytoestrogens. Similarly, of the 8 visual analogue scales used to indicate mood, 7 improved significantly after the treatment with phytoestrogens. Moreover, 49 patients preferred phytoestrogens, 9 placebo, and 18 had no preference. The preference was not related to the order of treatment. CONCLUSION(S): These results suggest that isoflavones may have positive effects on postmenopausal women improving cognitive performance and mood.
Authors: Vanize Mackedanz; Cristiane B Mattos; Luciane R Feksa; Clovis M D Wannmacher; Angela T S Wyse Journal: Metab Brain Dis Date: 2010-11-12 Impact factor: 3.584
Authors: Carey E Gleason; Cynthia M Carlsson; Jodi H Barnet; Sarah A Meade; Kenneth D R Setchell; Craig S Atwood; Sterling C Johnson; Michele L Ries; Sanjay Asthana Journal: Age Ageing Date: 2008-12-02 Impact factor: 10.668
Authors: Steven L Neese; Victor C Wang; Daniel R Doerge; Kellie A Woodling; Juan E Andrade; William G Helferich; Donna L Korol; Susan L Schantz Journal: Neurotoxicol Teratol Date: 2009-11-27 Impact factor: 3.763
Authors: Steven L Neese; Samantha L Pisani; Daniel R Doerge; William G Helferich; Estatira Sepehr; Amar G Chittiboyina; Sateesh Chandra Kumar Rotte; Troy J Smillie; Ikhlas A Khan; Donna L Korol; Susan L Schantz Journal: Neurotoxicol Teratol Date: 2013-12-22 Impact factor: 3.763